February 14, 2026 02:53 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Rs 5,000 to women ahead of Tamil Nadu polls! Vijay slams Stalin, says: ‘take the money, blow the whistle’ | Modi congratulates Tarique Rahman as BNP clinches majority in Bangladesh polls | Bangladesh Polls: Tarique Rahman-led BNP secures 'absolute majority' with 151 seats in historic comeback | BJP MP files notice to cancel Rahul Gandhi's Lok Sabha membership, seeks life-long ban | Arrested in the morning, out by evening: Tycoon’s son walks free in Lamborghini crash case | ‘Why should you denigrate a section of society?’: Supreme Court pulls up ‘Ghooskhor Pandat’ makers | Bangladesh poll manifestos mirror India’s welfare schemes as BNP, Jamaat bet big on women, freebies | Drama ends: Pakistan makes U-turn on India boycott, to play T20 World Cup clash as per schedule | ‘Won’t allow any impediment in SIR’: Supreme Court pulls up Mamata govt over delay in sharing officers’ details | India-US trade deal: ‘Negotiations always two-way’, says Amul MD amid farmers’ concerns
Covidd-19 Vaccine

Vaccine by the end of 2020 possible, says Union health minister

| @indiablooms | Aug 31, 2020, at 10:47 pm

New Delhi/IBNS: Union health and family welfare minister Dr Harshvardhan said on Monday that a vaccine might be ready in the country by the end of this year, said media report.

The minister said India is not lagging behind anyone else in the world in efforts to contribute towards the development of a coronavirus vaccine.

There are 7-8 vaccine candidates, three of them in the clinical trial phase and the rest in the pre-clinical phase, he informed.

Currently, two vaccine candidates developed in India — Covaxin by Bharat Biotech and ZyCoV-D by Zydus Cadila are in the midst of phase II clinical trial, while Covishield by the University of Oxford has recently started the phase II clinical trial in India.

Vaccine manufacturer AstraZeneca has entered into an agreement with Serum Institute of India to manufacture Oxford's COVID-19 vaccine candidate for India and countries in the low-income group.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.